Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0NR6T
|
|||
| Former ID |
DNCL001948
|
|||
| Drug Name |
UB-311
|
|||
| Indication | Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9; ICD-9: 331] | Phase 2 | [1] | |
| Company |
United Biomedical
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02551809) Evaluate the Safety, Tolerability, Immunogenicity and Efficacy of UB-311 in Mild Alzheimer's Disease (AD) Patients. | |||
| REF 2 | Active immunotherapy options for Alzheimer's disease. Alzheimers Res Ther. 2014; 6(1): 7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.